255 related articles for article (PubMed ID: 15231048)
41. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants.
Klier CM; Schmid-Siegel B; Schäfer MR; Lenz G; Saria A; Lee A; Zernig G
J Clin Psychiatry; 2006 Feb; 67(2):305-9. PubMed ID: 16566628
[TBL] [Abstract][Full Text] [Related]
42. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort.
Kumar V; Mdzinarishvili A; Kiewert C; Abbruscato T; Bickel U; van der Schyf CJ; Klein J
J Pharmacol Sci; 2006 Sep; 102(1):47-54. PubMed ID: 16936454
[TBL] [Abstract][Full Text] [Related]
43. St. John's wort does not interfere with therapeutic drug monitoring of 12 commonly monitored drugs using immunoassays.
Dasgupta A; Tso G; Szelei-Stevens K
J Clin Lab Anal; 2006; 20(2):62-7. PubMed ID: 16538644
[TBL] [Abstract][Full Text] [Related]
44. St. John's wort.
Lawvere S; Mahoney MC
Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
[TBL] [Abstract][Full Text] [Related]
45. Batch-to-batch reproducibility of St. John's wort preparations.
Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilovecz M
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S152-6. PubMed ID: 11518067
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
47. Effect of St. John's wort on free radical production.
Hunt EJ; Lester CE; Lester EA; Tackett RL
Life Sci; 2001 Jun; 69(2):181-90. PubMed ID: 11441908
[TBL] [Abstract][Full Text] [Related]
48. The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men.
Siepmann M; Krause S; Joraschky P; Mück-Weymann M; Kirch W
Br J Clin Pharmacol; 2002 Sep; 54(3):277-82. PubMed ID: 12236848
[TBL] [Abstract][Full Text] [Related]
49. Potential for interaction of kava and St. John's wort with drugs.
Singh YN
J Ethnopharmacol; 2005 Aug; 100(1-2):108-13. PubMed ID: 16005588
[TBL] [Abstract][Full Text] [Related]
50. St. John's Wort reduces beta-amyloid accumulation in a double transgenic Alzheimer's disease mouse model-role of P-glycoprotein.
Brenn A; Grube M; Jedlitschky G; Fischer A; Strohmeier B; Eiden M; Keller M; Groschup MH; Vogelgesang S
Brain Pathol; 2014 Jan; 24(1):18-24. PubMed ID: 23701205
[TBL] [Abstract][Full Text] [Related]
51. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions.
Galeotti N
J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196
[TBL] [Abstract][Full Text] [Related]
52. Optimized and Validated HPLC Analysis of St. John's Wort Extract and Final Products by Simultaneous Determination of Major Ingredients.
Zeliou K; Kontaxis NI; Margianni E; Petrou C; Lamari FN
J Chromatogr Sci; 2017 Sep; 55(8):805-812. PubMed ID: 28472287
[TBL] [Abstract][Full Text] [Related]
53. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
[TBL] [Abstract][Full Text] [Related]
54. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
Markowitz JS; DeVane CL
Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
[TBL] [Abstract][Full Text] [Related]
55. [Quantitative analysis of active substances in St. John's wort (Hypericum perforatum L.) by the high performance liquid chromatography method].
Kazlauskas S; Bagdonaite E
Medicina (Kaunas); 2004; 40(10):975-81. PubMed ID: 15516821
[TBL] [Abstract][Full Text] [Related]
56. A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults.
Cui YH; Zheng Y
Neuropsychiatr Dis Treat; 2016; 12():1715-23. PubMed ID: 27468236
[TBL] [Abstract][Full Text] [Related]
57. Hyperforin as a possible antidepressant component of hypericum extracts.
Chatterjee SS; Bhattacharya SK; Wonnemann M; Singer A; Müller WE
Life Sci; 1998; 63(6):499-510. PubMed ID: 9718074
[TBL] [Abstract][Full Text] [Related]
58. The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver.
Dostalek M; Pistovcakova J; Jurica J; Sulcova A; Tomandl J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):253-7. PubMed ID: 22286810
[TBL] [Abstract][Full Text] [Related]
59. Effects of St. John's wort supplementation on ibuprofen pharmacokinetics.
Bell EC; Ravis WR; Lloyd KB; Stokes TJ
Ann Pharmacother; 2007 Feb; 41(2):229-34. PubMed ID: 17284505
[TBL] [Abstract][Full Text] [Related]
60. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]